Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romidepsin and Bortezomib in Relapsed Myeloma
NCT00431990Phase 2Unknown
- Sponsor
- Peter MacCallum Cancer Centre
- Start
- Nov 2006
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of romidepsin in multiple myeloma (MM), sponsored by Peter MacCallum Cancer Centre. Status: unknown.
02
Drugs
romidepsin
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00431990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00431990.